Step 1 of 6
Detection & Initial Triage
Palpable swelling vs incidentaloma — establish how the nodule was found and frame the workup
Thyroid nodules present along two main routes — clinically detected (palpable neck swelling, noted on routine examination) or radiologically detected ("incidentaloma" on US, CT, MRI, PET-CT, carotid Doppler, or cervical spine imaging). The mode of detection shapes baseline risk and the urgency of workup.
The 2015 ATA guideline frames evaluation around six integrated risk domains — clinical, functional, structural, cytologic, molecular, and biological behaviour. The same physical nodule can carry very different management implications depending on the compendium of these inputs.
- Clinically detected — palpation, asymmetry, dysphagia
- Incidentaloma — US, CT, MRI, carotid Doppler, spine imaging
- PET-CT FDG-avid focal nodule — high-risk class apart (40–56 %)
- Frame the six risk domains from the first encounter
Key statistics
Prevalence palpable nodules
4–7%
Adult general population; rises with age
Haugen 2016 ATA 2015 guideline §A.1 quotes 4–7% palpable prevalence · PMID 26462967
Prevalence US-detected nodules
19–68%
Ultrasound is more sensitive than palpation by an order of magnitude
Haugen 2016 ATA 2015 §A.1 — 19–68% with high-resolution US · PMID 26462967
PET-CT incidentaloma malignancy risk
40–56%
Mandates US + FNA regardless of TI-RADS
Nayan 2014 meta-analysis 35% pooled prevalence; Soelberg 22827552, Bertagna 23179777 corroborate · PMID 24759908
★ High-yield pearls (chapter-wide)
- The six risk domains (clinical · functional · structural · cytologic · molecular · biological behaviour) are evaluated in parallel, not in sequence.
- Rule out phaeochromocytoma BEFORE any thyroid surgery in suspected medullary carcinoma or MEN2 — unrecognised pheo at induction is fatal.
- PET-CT incidentaloma (FDG-avid focal thyroid nodule) carries 40–56 % malignancy risk — mandates ultrasound + FNA regardless of TI-RADS.
- Hot nodules on scintigraphy have ~4–5 % malignancy risk and rarely need FNA; cold nodules carry ~15 % risk and need ultrasound-guided FNA.
- Bethesda III–IV (indeterminate) is where molecular testing earns its keep — ThyroSeq rules in, Afirma rules out.
- Papillary microcarcinoma (<1 cm, low-risk, intrathyroidal) is a candidate for active surveillance; not every malignancy demands surgery.
- Anaplastic carcinoma is an airway emergency until proven otherwise — secure airway before workup.
Evidence base
6 sources- HIGH
Tan GH & Gharib H · Ann Intern Med · 1997Foundational narrative reviewPMID 9027275
Foundational article defining incidentaloma management — established the conceptual framework for evaluating nonpalpable thyroid nodules discovered on imaging. Vol 126(3):226-231.
- HIGH
Soelberg KK et al. · Thyroid · 2012Systematic review / meta-analysisPMID 22827552
Systematic review quantifying malignancy risk in focal FDG-avid thyroid incidentalomas — anchors the 30–40 % malignancy figure that drives mandatory US + FNA workup. Vol 22(9):918-925.
- MOD
Bertagna F et al. · Endocrine · 2013Multicentre retrospective studyPMID 23179777
Multicentre retrospective analysis supporting the malignancy risk of focal PET uptake; complements Soelberg systematic review by adding Italian cohort data. Vol 43(3):678-685.
- HIGH
Nayan S, Ramakrishna J, Gupta MK · Otolaryngol Head Neck Surg · 2014Systematic review / meta-analysisPMID 24759908
Meta-analysis converging on 35 % malignancy prevalence for focal PET-avid thyroid incidentalomas — independent confirmation of Soelberg's bands. Vol 151(2):190-200.
- HIGH
Yip L & Sosa JA · JAMA Surg · 2016Expert reviewPMID 27223483
Modern molecular-directed paradigm for DTC diagnosis and treatment — frames the integrated 6-domain risk evaluation that this chapter mirrors. Vol 151(7):663-670.
- HIGH
Haugen BR et al. · Thyroid · 2016International guideline (ATA)PMID 26462967
ATA 2015 management guideline for adult thyroid nodules and DTC — anchors nodule workup, FNAB thresholds, lobectomy vs total thyroidectomy, RAI indications, TSH suppression targets, and dynamic risk stratification across this chapter. Vol 26(1):1-133.